Showing results (161-170 of 243) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|December 21, 2013
Chronic thromboembolic pulmonary hypertensionNick H Kim, Marion Delcroix, David P Jenkins, et al.
Internal and Emergency Medicine|May 24, 2018
Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registrySophie Testa, Walter Ageno, Emilia Antonucci, et al.
Internal and Emergency Medicine|November 7, 2019
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS studyGualtiero Palareti, Cristina Legnani, Emilia Antonucci, et al.
International Journal of Laboratory Hematology|December 11, 2024
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid RegistryAnna Aiello, Luca Sarti, Gilda Sandri, et al.
The New England Journal of Medicine|May 28, 2004
Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolismVittorio Pengo, Anthonie W A Lensing, Martin H Prins, et al.
The New England Journal of Medicine|October 27, 2006
D-dimer testing to determine the duration of anticoagulation therapyGualtiero Palareti, Benilde Cosmi, Cristina Legnani, et al.
Angiology|August 27, 2024
ACEF vs PARIS score in Predicting Cardiovascular Events in Patients With Acute Coronary Syndrome: Insights From the START ANTIPLATELET RegistryPlinio Cirillo, Luigi Di Serafino, Maria Scalamogna, et al.
Thrombosis Research|December 3, 2014
Incidence of a first thromboembolic event in carriers of isolated lupus anticoagulantVittorio Pengo, Sophie Testa, Ida Martinelli, et al.
Immunologic Research|July 14, 2016
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndromeEntela Nuri, Mara Taraborelli, Laura Andreoli, et al.
The American Journal of Cardiology|July 31, 2018
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry)Giuseppe Patti, Elisabetta Ricottini, Antonio Nenna, et al.
Pageof 25